Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Classical hematology 1

Conditions

Thrombocytopenia 1Stomach Neoplasms 1Neutropenia 1Neoplasms, Plasma Cell 1Esophageal Neoplasms 1Colorectal Neoplasms 1Appendiceal Neoplasms 1

Interventions

Filgrastim 7pegylated granulocyte colony-stimulating factor 5pegfilgrastim 5Cytarabine 4Ciprofloxacin 4Cefepime 4Vancomycin 3Leucovorin 3Fluorouracil 3Amikacin 3trifluridine tipiracil drug combination 2Piperacillin, Tazobactam Drug Combination 2Methylprednisolone 2Meropenem 2Irinotecan 2Etoposide 2Daptomycin 2Cisplatin 2Ceftazidime 2ziprasidone 1trilaciclib 1sargramostim 1niraparib 1liposomal amphotericin B 1lintuzumab 1leridistim 1isavuconazole 1fludarabine phosphate 1flt3 ligand protein 1fish oil triglycerides 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Neutropenia × Algorithms × Clear all
NCT04526886 2025-10-06

Clinical Trial of a Novel Dose Adjustment Algorithm for Preventing Cytopenia-Related Delays During FOLFOX Chemotherapy

Dartmouth-Hitchcock Medical Center

Phase NA Completed
52 enrolled 8 charts
Classical hematologyGastrointestinal

Appendiceal Neoplasms, Esophageal Neoplasms, Neutropenia, Stomach Neoplasms, Thrombocytopenia, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡